IP Watchdog

AUGUST 12, 2024

Supreme Court’s reasoning in Helsinn Healthcare v. Teva Pharmaceuticals (2019), the Federal Circuit rejected Celanese’s contentions that statutory changes wrought by the America Invents Act (AIA) altered the on-sale bar such that sales of products manufactured by an undisclosed process would not invalidate patents claiming that process.

Pharmaceuticals 64

Pharmaceuticals Healthcare Manufacturing Technology 64

InHouseBlog

APRIL 8, 2022

Senior Director, Compliance Risk Navigation , Regeneron Pharmaceuticals (Tarrytown, NY). Associate GC and Member Relations Executive , National Electrical Manufacturers Association (Arlington, VA). AGC – Rapidly Growing Startup Healthcare Company , Beacon Hill Staffing Group (Boston, MA). Product Counsel , Wayfair Inc.

Real Estate 97

Real Estate Pharmaceuticals Litigation Technology 97

Complex Discovery

OCTOBER 15, 2024

The report also underscores the agencies’ strengthened enforcement efforts, with 28 merger challenges in key sectors like healthcare, technology, and consumer goods. These enforcement actions targeted critical sectors, including pharmaceuticals, healthcare, technology, and energy. of the total​.

Pharmaceuticals 59

Pharmaceuticals Healthcare Technology Manufacturing 59

Complex Discovery

FEBRUARY 12, 2025

The technology, healthcare, and financial services sectors continue to be the most active in corporate transactions, each influenced by unique market drivers, regulatory challenges, and digital transformation initiatives. Companies must now demonstrate how acquisitions will not result in market monopolization or unfair competitive advantages.

Healthcare 52

Healthcare Pharmaceuticals Technology Manufacturing 52